Bladder cancer, Breast cancer, Lung cancer, Non small cell lung cancer (NSCLC), Oesophageal cancer, Ovarian cancer, Pancreatic cancer, Sarcoma, Secondary cancers, Soft tissue sarcoma, Stomach cancer, Transitional cell cancer
Results
Phase 2
This trial looked at brivanib to see if it improved treatment for certain types of .
It was for people whose cancer had spread and they had no options available to them.
A solid tumour is any type of cancer apart from leukaemia, lymphoma or myeloma.
This trial was open for people to join between 2008 and 2011. The team published the results in 2019.
Recruitment start: 4 June 2008
Recruitment end: 30 August 2011
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Stan Kaye
Bristol-Myers Squibb
Experimental Cancer Medicine Centre (ECMC)
Last reviewed: 8 September 2024
CRUK internal database number: 4065
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
